Womed's mission is to help women improve their fertility by protecting and restoring their uterus for pregnancy.

History

Womed Leaf stems from research conducted at Pr Garric's biopolymer lab at the University of Montpellier, France, and which aimed at finding an elegant solution to an unmet medical need in gynecologic surgery: intrauterine adhesions. The research project started in 2013 and was conducted as the thesis work of several PhD students. At the conclusion of the thesis, the lab looked for an industrial partner to commercialize the invention. Womed SAS was incorporated in 2018 for that purpose.

​

Womed is dedicated to quality and is ISO 13485 certified.

Co founders

Screenshot 2020-09-02 at 12.12.44.png

Gonzague Issenmann

Chairman

Medtech entrepreneur

Screenshot 2020-09-02 at 12.13.26.png

Xavier Garric, PhD

Scientific consultant

University Professor
Director of the Artificial Biopolymer Lab, University of Montpellier (IBMM), France

Screenshot 2020-09-02 at 12.13.32.png

Stephanie Huberlant, PhD

Medical consultant

Obstetric and gynaecology surgeon, 

 reproductive specialist

CHU Carémeau, France

Medical advisors

H.Fernandez-removebg-preview.png

Hervé Fernandez, MD, PhD

Director of gynaecology and obstetrics department at Kremlin Bicêtre, Paris, France

ki-removebg-preview.png

Keith Isaacson,   MD

Director of minimally invasive gynaecologic surgery and Infertility, Newton Wellesley Hospital, USA. Associate Professor of Obstetrics and Gynecology

Andreas Thurkow,

MD

Gynaecology surgeon specialized in minimal invasive surgery at Bergman Clinics Amsterdam and affiliated with the Amsterdam University Medical Centres, the Netherlands

Angelo-Hooker-1-removebg-preview_edited_

Angelo Hooker,

MD

Obstetrics and gynaecology surgeon at Zaans medical center, the Netherlands